Actively Recruiting
Evaluating Early Return-to-Work Consultation for Adults with Blood Cancers to Improve Work Reintegration
Led by University Hospital, Angers · Updated on 2026-09-04
264
Participants Needed
10
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying patients who have been treated for hematological malignancies such as leukemia, lymphoma, and multiple myeloma. The study aims to evaluate whether an early return-to-work after cancer consultation can improve the rate and quality of patients returning to work. This prospective, randomized, multicenter study focuses on supportive care, as returning to work is linked to better quality of life outcomes including financial stability and social engagement. Participants will be divided into two groups one receiving the specialized return-to-work consultation and the other receiving standard care without this consultation. The consultation is conducted by a specialist in occupational pathology and may include support from a psychologist, nurse, or social worker. It lasts about one hour and addresses medical, social, and psychological factors affecting return to work, offering guidance and solutions tailored to each participants situation. During the study, participants return-to-work status will be monitored over 12 months. The research team will assess various outcomes including return-to-work rates, changes in professional status, quality of life, anxiety and depression levels, and self-efficacy related to returning to work. Evaluations will be done at baseline and at 3, 6, and 12 months. Participants will also self-assess the benefit of the consultation at 3 and 6 months. The study will continue through March 2028.
CONDITIONS
Brief Title
RAT-HEMATO : Return to Work After Malignant Hemopathy
Research Team
J
Jérome PAILLASSA, MD
A
Aline SCHMIDT, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here